SCHEMBL17255846

SCHEMBL17255846

CCCCCCCCC(CCCCCCCCC(=O)OC)S(=O)(=O)CC.CCCCCCCCCC(CCCCCCCC(=O)O)S(=O)(=O)CC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR4 Q5NUL3 2/20 0.51
▸ FFAR1 O14842 2/20 0.51
▸ TSHR P16473 5/20 0.50
▸ GPR84 Q9NQS5 7/20 0.49
▸ PPARG P37231 7/20 0.49
▸ PPARD Q03181 7/20 0.49
▸ PPARA Q07869 7/20 0.49
▸ HDAC11 Q96DB2 5/20 0.49
▸ PTPN1 P18031 3/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ TLR2 O60603 2/20 0.49
▸ TDP1 Q9NUW8 2/20 0.49
▸ FABP4 P15090 2/20 0.49
▸ SLC22A6 Q4U2R8 1/20 0.49
▸ SLC22A8 Q8TCC7 1/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ ESR1 P03372 1/20 0.49
▸ ALOX15 P16050 1/20 0.49
▸ PDE4A P27815 1/20 0.49
▸ KMT2A Q03164 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15823849 0.94 CA12 (0.50) TSHRPPARGPPARAALDH1A1MEN1
SCHEMBL15824674 0.94 CA12 (0.50) TSHRPPARGPPARAALDH1A1MEN1
SCHEMBL15833854 0.93 CA12 (0.49) TSHRPPARGPPARAALDH1A1MEN1
SCHEMBL15833853 0.93 CA12 (0.49) TSHRPPARGPPARAALDH1A1MEN1
SCHEMBL15833856 0.93 CA12 (0.49) TSHRPPARGPPARAALDH1A1MEN1
SCHEMBL17255848 0.92 FFAR4 (0.49) FFAR4FFAR1TSHRGPR84PPARG
SCHEMBL17255858 0.92 FFAR4 (0.49) FFAR4FFAR1TSHRGPR84PPARG
SCHEMBL15833791 0.89 FFAR4 (0.62) FFAR4FFAR1TSHRGPR84PPARG
SCHEMBL15833855 0.88 CA12 (0.48) TSHRPPARGPPARAMEN1KMT2A
SCHEMBL15823932 0.87 CA12 (0.44) TSHRPPARGPPARAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150329484-A1 ESTER HAVING SULPHONE GROUP EVONIK DEGUSSA GMBH (DE) 2015-11-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150329484-A1 ESTER HAVING SULPHONE GROUP STS, SULT1A1, TST FFAR4 588/4885FFAR1 995/4885TSHR 4108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback